Gregg Anthony Lapointe Insider Trading Transactions
Get free email notifications about insider trading for Gregg Anthony Lapointe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gregg Anthony Lapointe. Gregg Anthony Lapointe is Director in SOLIGENIX, INC. ($DOR) and Director in QUESTCOR PHARMACEUTICALS INC ($QSC) and Director in SCICLONE PHARMACEUTICALS INC ($SCLN) and Director in Raptor Pharmaceutical Corp ($RPTP) and Director in ImmunoCellular Therapeutics, Ltd. ($IMUC) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in CYTORI THERAPEUTICS, INC. ($XMP) and Director in CATABASIS PHARMACEUTICALS INC ($CATB).
Latest Insider Trading Transactions of Gregg Anthony Lapointe
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CATB, RPTP, IMUC, PSTV, QSC, RIGL, SCLN, SNGX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | CATB | CATABASIS PHARMACE ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 2.04 | 100,000 | 204,000 | 100,000 | |
Sep 18 2020 | SNGX | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 1.97 | 15,228 | 29,999 | 15,228 | |
Jun 12 2020 | CATB | CATABASIS PHARMACE ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
May 24 2019 | RIGL | RIGEL PHARMACEUTIC ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 2.02 | 55,000 | 111,100 | 55,000 | |
Feb 15 2019 | CATB | CATABASIS PHARMACE ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 4.39 | 12,200 | 53,558 | 12,200 | |
Jan 04 2019 | CATB | CATABASIS PHARMACE ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 4.90 | 2,800 | 13,720 | 2,800 | |
Sep 28 2018 | SNGX | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 1.67 | 17,964 | 30,000 | 17,964 | |
May 18 2018 | RIGL | RIGEL PHARMACEUTIC ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 3.98 | 30,000 | 119,400 | 30,000 | |
Nov 02 2017 | RIGL | RIGEL PHARMACEUTIC ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 3.80 | 80,000 | 304,000 | 80,000 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 10.90 | 30,000 | 327,000 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 9.15 | 30,000 | 274,500 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 5.10 | 30,000 | 153,000 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 5.13 | 30,000 | 153,900 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 6.78 | 30,000 | 203,400 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 6.04 | 30,000 | 181,200 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 3.01 | 30,000 | 90,300 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 2.23 | 5,000 | 11,150 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 1.24 | 50,000 | 62,000 | 0 | |
Jun 12 2017 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 2.29 | 13,100 | 29,999 | 13,100 | |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 10.90 | 30,000 | 327,000 | 30,000 | |
May 24 2017 | XMP | CYTORI THERAPEUTIC ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 1.60 | 50,000 | 80,000 | 50,000 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 5.22 | 7,915 | 41,316 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Sell | D | 9.00 | 8,330 | 74,970 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Sell | U | 9.00 | 2,092 | 18,828 | 8,330 | 10.4 K to 8.3 K (-20.07 %) |
Jun 27 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Grant | A | 0.00 | 8,330 | 0 | 10,422 | 2.1 K to 10.4 K (+398.18 %) |
Jun 21 2016 | IMUC | ImmunoCellular The ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 0.24 | 156,750 | 37,620 | 156,750 | |
Jun 13 2016 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 14.00 | 30,000 | 419,850 | 30,000 | |
Apr 19 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 5.22 | 7,915 | 41,316 | 7,915 | |
Apr 19 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Grant | A | 0.00 | 2,092 | 0 | 2,092 | 0 to 2.1 K |
Sep 22 2015 | IMUC | ImmunoCellular The ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 0.47 | 40,000 | 18,800 | 40,000 | |
Aug 31 2015 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | M | 0.30 | 25,000 | 7,500 | 0 | |
Aug 31 2015 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Buy | M | 0.30 | 25,000 | 7,500 | 73,781 | 48.8 K to 73.8 K (+51.25 %) |
Jun 19 2015 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 1.51 | 19,868 | 30,001 | 19,868 | |
Jun 12 2015 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 9.15 | 30,000 | 274,500 | 30,000 | |
Oct 13 2009 | QSC | QUESTCOR PHARMACEU ... | Lapointe Gregg Anthony | Director | Option Exercise | A | 5.58 | 5,000 | 27,900 | 5,000 | |
Oct 13 2009 | QSC | QUESTCOR PHARMACEU ... | Lapointe Gregg Anthony | Director | Option Exercise | A | 5.58 | 25,000 | 139,500 | 25,000 | |
Aug 12 2005 | QSC | QUESTCOR PHARMACEU ... | Lapointe Gregg Anthony | Director | Option Exercise | A | 0.61 | 5,000 | 3,050 | 5,000 | |
Jul 01 2005 | QSC | QUESTCOR PHARMACEU ... | Lapointe Gregg Anthony | Director | Option Exercise | A | 0.65 | 25,000 | 16,250 | 25,000 |
Page: 1